Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Other Gross PP&E Adjustments (2016 - 2025)

Fortress Biotech has reported Other Gross PP&E Adjustments over the past 14 years, most recently at -$4.6 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 407.83% year-over-year to -$4.6 million; the TTM value through Dec 2025 reached -$4.6 million, down 407.83%, while the annual FY2025 figure was -$4.6 million, 407.83% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$4.6 million at Fortress Biotech, up from -$5.7 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $5.7 million in Q1 2022 and troughed at -$7.3 million in Q2 2025.
  • A 5-year average of -$151150.0 and a median of -$242000.0 in 2024 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: soared 583.42% in 2022 and later plummeted 1523.63% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $5.5 million in 2021, then increased by 0.37% to $5.5 million in 2022, then tumbled by 129.1% to -$1.6 million in 2023, then skyrocketed by 194.6% to $1.5 million in 2024, then crashed by 407.83% to -$4.6 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for FBIO at -$4.6 million in Q4 2025, -$5.7 million in Q3 2025, and -$7.3 million in Q2 2025.